WO2006023502A3 - Particle/cell separation device and compositions - Google Patents

Particle/cell separation device and compositions Download PDF

Info

Publication number
WO2006023502A3
WO2006023502A3 PCT/US2005/029136 US2005029136W WO2006023502A3 WO 2006023502 A3 WO2006023502 A3 WO 2006023502A3 US 2005029136 W US2005029136 W US 2005029136W WO 2006023502 A3 WO2006023502 A3 WO 2006023502A3
Authority
WO
WIPO (PCT)
Prior art keywords
particle
separation device
cell separation
compositions
rich plasma
Prior art date
Application number
PCT/US2005/029136
Other languages
French (fr)
Other versions
WO2006023502A2 (en
Inventor
Allan Mishra
Original Assignee
Allan Mishra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allan Mishra filed Critical Allan Mishra
Publication of WO2006023502A2 publication Critical patent/WO2006023502A2/en
Publication of WO2006023502A3 publication Critical patent/WO2006023502A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells

Abstract

A particle / cell separation device is described which is particularly adapted for neutrophil depletion from a preparation of whole blood or platelet-rich plasma. Also described are blood and platelet rich plasma compositions produced using the device which are neutrophil-depleted.
PCT/US2005/029136 2004-08-20 2005-08-17 Particle/cell separation device and compositions WO2006023502A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60324904P 2004-08-20 2004-08-20
US60/603,249 2004-08-20

Publications (2)

Publication Number Publication Date
WO2006023502A2 WO2006023502A2 (en) 2006-03-02
WO2006023502A3 true WO2006023502A3 (en) 2006-06-01

Family

ID=35968112

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/029136 WO2006023502A2 (en) 2004-08-20 2005-08-17 Particle/cell separation device and compositions

Country Status (2)

Country Link
US (4) US7462268B2 (en)
WO (1) WO2006023502A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608258B2 (en) * 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
US6811777B2 (en) * 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
US20070122906A1 (en) * 2003-12-29 2007-05-31 Allan Mishra Method of culturing cells
WO2005065269A2 (en) * 2003-12-29 2005-07-21 Am Biosolutions Compositions and method for decreasing the appearance of skin wrinkles
US7678780B2 (en) * 2003-12-29 2010-03-16 Allan Mishra Method of treating cancer using platelet releasate
US7462268B2 (en) 2004-08-20 2008-12-09 Allan Mishra Particle/cell separation device and compositions
US20060095121A1 (en) * 2004-10-28 2006-05-04 Medtronic Vascular, Inc. Autologous platelet gel on a stent graft
US20070093748A1 (en) * 2005-06-23 2007-04-26 Medtronic Vascular, Inc. Methods and systems for treating injured cardiac tissue
US20070014784A1 (en) * 2005-06-23 2007-01-18 Medtronic Vascular, Inc. Methods and Systems for Treating Injured Cardiac Tissue
US20070172472A1 (en) * 2005-06-23 2007-07-26 Asha Nayak Methods and Systems for Treating Injured Cardiac Tissue
US20100112081A1 (en) * 2008-10-07 2010-05-06 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
JP2012505239A (en) * 2008-10-09 2012-03-01 バイオパラドックス，リミテッド ライアビリティー カンパニー Platelet-rich plasma preparation for heart treatment
US20100233282A1 (en) * 2009-03-13 2010-09-16 Allan Mishra Device and methods for delivery of bioactive materials to the right side of the heart
WO2011028733A1 (en) 2009-09-04 2011-03-10 Allan Mishra Compositions and minimally invasive methods for treating cancer
US20130017180A1 (en) * 2010-04-05 2013-01-17 Allan Mishra Platelet rich plasma formulations
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation
WO2020174005A1 (en) 2019-02-28 2020-09-03 The Regenerative Group Ltd. Regenerative combination of plasma and adipose tissue
CN114007650A (en) 2019-05-24 2022-02-01 诺欧生物有限责任公司 Light-activated blood products and methods and apparatus for making and using the same

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931395A (en) * 1986-12-08 1990-06-05 Dana-Farber Cancer Institute Monoclonal antibody specific to neutrophils
US5403272A (en) * 1992-05-29 1995-04-04 Baxter International Inc. Apparatus and methods for generating leukocyte free platelet concentrate
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US20020058030A1 (en) * 2000-05-03 2002-05-16 Eligix, Inc. Whole blood separator apparatus and method of use
US20030116512A1 (en) * 2001-12-05 2003-06-26 Glen Delbert Antwiler Methods and apparatus for separation of particles
US6643786B1 (en) * 1999-01-25 2003-11-04 Kabushiki Kaisha Toshiba Computer battery event managing method with option to compulsorily execute a low battery capacity operation even when a program of the computer does not respond
US6811777B2 (en) * 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081331A (en) * 1976-04-05 1978-03-28 Gunther Weiss Portable water distillation apparatus
US4414108A (en) * 1980-05-09 1983-11-08 The United States Of America As Represented By The Department Of Health And Human Services Apparatus and method for continuous countercurrent extraction and particle separation
CA1244774A (en) 1983-11-09 1988-11-15 Thomas Jefferson University Medium for storing blood platelets
JPS61502943A (en) 1984-06-22 1986-12-18 ビ−チ、リチャ−ド・エル Electrolyte solutions and their use in vivo
US5165938A (en) 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US5178883A (en) 1984-11-29 1993-01-12 Regents Of The University Of Minnesota Method for promoting hair growth
JPH0651060B1 (en) * 1986-03-28 1994-07-06 Asahi Medical Co
US5124316A (en) 1986-11-14 1992-06-23 President And Fellows Of Harvard College Method for periodontal regeneration
US5079236A (en) 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
US5428008A (en) 1989-04-14 1995-06-27 Prp, Inc. Therapeutic composition of micellar structures capable of promoting hemotasis
US5344561A (en) * 1989-05-09 1994-09-06 Pall Corporation Device for depletion of the leucocyte content of blood and blood components
IL95641A0 (en) 1989-09-15 1991-06-30 Curative Tech Inc Preparation of a platelet releasate product
US5599558A (en) 1989-09-15 1997-02-04 Curative Technologies, Inc. Selecting amounts of platelet releasate for efficacious treatment of tissue
US5147776A (en) 1990-02-26 1992-09-15 University Of Iowa Research Foundation Use of 2,5-anhydromannitol for control of pH during blood storage
JP2823690B2 (en) 1990-07-23 1998-11-11 ザイモジェネティクス，インコーポレイティド Protease resistant PDGF and methods of use
US5336387A (en) * 1990-09-11 1994-08-09 Bioseparations, Inc. Electrical separator apparatus and method of counterflow gradient focusing
US5641622A (en) * 1990-09-13 1997-06-24 Baxter International Inc. Continuous centrifugation process for the separation of biological components from heterogeneous cell populations
US5385937A (en) 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia
US5474891A (en) 1991-10-30 1995-12-12 Thomas Jefferson University Plasma-based platelet concentrate preparations with additive
US5785869A (en) * 1992-02-10 1998-07-28 Baxter International Inc. Method for creating a leukocyte rich sample from a mixed population of blood cells
US5269290B1 (en) 1992-04-17 1996-06-11 Instratek Inc Plantar fasciotomy surgical procedure
BR9306443A (en) * 1992-05-29 1998-06-30 Univ North Carolina Pharmaceutically acceptable dry and fixed human blood platelets
US5324284A (en) * 1992-06-05 1994-06-28 Cardiac Pathways, Inc. Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method
US5494590A (en) 1992-06-11 1996-02-27 Becton Dickinson Method of using anticoagulant solution in blood separation
US5449688A (en) 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases
EP0720658A1 (en) * 1993-09-23 1996-07-10 E.I. Du Pont De Nemours And Company An electrophoretic method for the isolation and separation of microorganisms
US5662813A (en) * 1994-10-21 1997-09-02 Bioseparations, Inc. Method for separation of nucleated fetal erythrocytes from maternal blood samples
US5789147A (en) * 1994-12-05 1998-08-04 New York Blood Center, Inc. Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
US7169547B2 (en) * 1994-12-05 2007-01-30 New York Blood Center, Inc. High concentration white blood cells as a therapeutic product
US5510102A (en) 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
US5614204A (en) 1995-01-23 1997-03-25 The Regents Of The University Of California Angiographic vascular occlusion agents and a method for hemostatic occlusion
US5643786A (en) 1995-01-27 1997-07-01 The United States Of America As Represented By The Department Of Health And Human Services Method for isolating dendritic cells
AUPN166195A0 (en) 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
US5913768A (en) * 1995-04-18 1999-06-22 Cobe Laboratories, Inc. Particle filter apparatus
US5814022A (en) 1996-02-06 1998-09-29 Plasmaseal Llc Method and apparatus for applying tissue sealant
US5834418A (en) 1996-03-20 1998-11-10 Theratechnologies, Inc. Process for the preparation of platelet growth factors extract
DE19781869T1 (en) * 1996-04-30 2000-03-16 Medtronic Inc Process for the production of an autologous fibrin hemostatic agent
WO2000062828A1 (en) * 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
US6280473B1 (en) 1996-08-19 2001-08-28 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US5935850A (en) 1996-09-30 1999-08-10 The Research Foundation Of State University Of New York Model for cell migration and use thereof
US6120520A (en) * 1997-05-27 2000-09-19 Angiotrax, Inc. Apparatus and methods for stimulating revascularization and/or tissue growth
ATE489633T1 (en) * 1997-06-10 2010-12-15 Lpath Inc METHOD FOR EARLY DETECTION OF HEART DISEASES
US6098631A (en) 1998-01-21 2000-08-08 The Regents Of The University Of Michigan Compositions and methods for treating autoimmune disease
US6712851B1 (en) 1998-01-23 2004-03-30 Macropore Biosurgery, Inc. Resorbable, macro-porous non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US6183442B1 (en) 1998-03-02 2001-02-06 Board Of Regents Of The University Of Texas System Tissue penetrating device and methods for using same
JP2002519155A (en) 1998-07-02 2002-07-02 スティヒティング・スケルトル・ティシュー・エンジニアリング・グループ・アムステルダム Bone cement with antimicrobial peptide
AU759991B2 (en) 1998-08-26 2003-05-01 Neo Mend, Inc. Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers or covering structures
US6322785B1 (en) 1999-03-02 2001-11-27 Natrex Technologies Methods and compositions for bone graft implants
US6432119B1 (en) 1999-03-17 2002-08-13 Angiotrax, Inc. Apparatus and methods for performing percutaneous myocardial revascularization and stimulating angiogenesis using autologous materials
US6315992B1 (en) 1999-06-30 2001-11-13 Tissuegene Co. Generating cartilage in a mammal using fibroblasts transfected with a vector encoding TGF-β-1
US6454804B1 (en) 1999-10-08 2002-09-24 Bret A. Ferree Engineered tissue annulus fibrosis augmentation methods and apparatus
DE19960504A1 (en) * 1999-12-15 2001-08-16 Curasan Ag Regenerating agent
US6447443B1 (en) * 2001-01-13 2002-09-10 Medtronic, Inc. Method for organ positioning and stabilization
US6592566B2 (en) 2000-02-03 2003-07-15 Arizona Board Of Regents Method for forming an endovascular occlusion
US20020006437A1 (en) 2000-05-01 2002-01-17 Grooms Jamie M. Non-migration tissue capsule
BR0112109A (en) 2000-06-29 2007-05-29 Biosyntech Canada Inc composition and method for the correction and regeneration of cartilage and other tissues
US20030185812A1 (en) 2000-06-30 2003-10-02 Ferree Bret A. Method of treating dural leaks with platelet-rich plasma (PRP)
US20020032155A1 (en) 2000-06-30 2002-03-14 Ferree Bret A. Method of treating disc herniation and disc degeneration with concentrated growth and differentiation factors
US6554801B1 (en) * 2000-10-26 2003-04-29 Advanced Cardiovascular Systems, Inc. Directional needle injection drug delivery device and method of use
US7740623B2 (en) 2001-01-13 2010-06-22 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
US7628780B2 (en) * 2001-01-13 2009-12-08 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
US6837848B2 (en) * 2003-01-15 2005-01-04 Medtronic, Inc. Methods and apparatus for accessing and stabilizing an area of the heart
US6942880B1 (en) * 2001-04-09 2005-09-13 Medtronic, Inc. Autologous platelet gel having beneficial geometric shapes and methods of making the same
US20030152639A1 (en) 2001-07-03 2003-08-14 Calvin Britton Novel wound healing composition not containing bovine-derived activating reagents
ES2386280T3 (en) 2001-08-09 2012-08-16 Giuseppe Intini Tissue implants and method for preparing and using them
US7241281B2 (en) * 2002-04-08 2007-07-10 Thermogenesis Corporation Blood component separation method and apparatus
US7211191B2 (en) * 2004-09-30 2007-05-01 Thermogenesis Corp. Blood component separation method and apparatus
US20030192554A1 (en) 2002-04-11 2003-10-16 Ferree Bret A. Methods and apparatus for adhering musculoskeletal tissues
US7608258B2 (en) 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
US20030205538A1 (en) * 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US20040182795A1 (en) * 2003-03-21 2004-09-23 Randel Dorian Apparatus and method for concentration of plasma from whole blood
US6905612B2 (en) * 2003-03-21 2005-06-14 Hanuman Llc Plasma concentrate apparatus and method
US20030224455A1 (en) * 2002-05-28 2003-12-04 Mariapia Abbracchio Method for the diagnosis of heart diseases
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
US6982038B2 (en) * 2002-06-14 2006-01-03 Medtronic, Inc. Centrifuge system utilizing disposable components and automated processing of blood to collect platelet rich plasma
US7674250B2 (en) * 2002-08-05 2010-03-09 Boston Scientific Scimed, Inc. Methods of delivering therapeutic agents
AR047712A1 (en) 2002-09-07 2006-02-15 Royal Veterinary College TREATMENT METHOD OF A NATURAL SOFT SKELETTIC TISSUE INJURY MANAGING A COMPOSITION OF MESENQUIMATOSE MOTHER CELLS
US20040126885A1 (en) 2002-11-05 2004-07-01 Cines Douglas B. Delivery vehicle for recombinant proteins
US20050064042A1 (en) 2003-04-29 2005-03-24 Musculoskeletal Transplant Foundation Cartilage implant plug with fibrin glue and method for implantation
US20040244806A1 (en) 2003-06-09 2004-12-09 Ferree Bret A. Treating disc herniation and other conditions with leukocytes
US7338494B2 (en) 2003-08-19 2008-03-04 Synthes (U.S.A.) Spring-loaded awl
US7678780B2 (en) 2003-12-29 2010-03-16 Allan Mishra Method of treating cancer using platelet releasate
WO2005065269A2 (en) 2003-12-29 2005-07-21 Am Biosolutions Compositions and method for decreasing the appearance of skin wrinkles
US20070122906A1 (en) 2003-12-29 2007-05-31 Allan Mishra Method of culturing cells
US7462268B2 (en) * 2004-08-20 2008-12-09 Allan Mishra Particle/cell separation device and compositions
EP1848474B1 (en) * 2005-02-07 2013-06-12 Hanuman LLC Platelet rich plasma concentrate apparatus and method
US8092475B2 (en) 2005-04-15 2012-01-10 Integra Lifesciences (Ireland) Ltd. Ultrasonic horn for removal of hard tissue
US20070014784A1 (en) 2005-06-23 2007-01-18 Medtronic Vascular, Inc. Methods and Systems for Treating Injured Cardiac Tissue
JP2012505239A (en) * 2008-10-09 2012-03-01 バイオパラドックス，リミテッド ライアビリティー カンパニー Platelet-rich plasma preparation for heart treatment

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931395A (en) * 1986-12-08 1990-06-05 Dana-Farber Cancer Institute Monoclonal antibody specific to neutrophils
US5403272A (en) * 1992-05-29 1995-04-04 Baxter International Inc. Apparatus and methods for generating leukocyte free platelet concentrate
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US6643786B1 (en) * 1999-01-25 2003-11-04 Kabushiki Kaisha Toshiba Computer battery event managing method with option to compulsorily execute a low battery capacity operation even when a program of the computer does not respond
US20020058030A1 (en) * 2000-05-03 2002-05-16 Eligix, Inc. Whole blood separator apparatus and method of use
US20030116512A1 (en) * 2001-12-05 2003-06-26 Glen Delbert Antwiler Methods and apparatus for separation of particles
US6811777B2 (en) * 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YANG J ET AL: "Dielectric properties of human leukocyte subpopulations determined by electrorotation as a cell separation criterion.", BIOPHYSICAL JOURNAL., vol. 76, 1999, pages 3307 - 3314, XP002996512 *

Also Published As

Publication number Publication date
US7462268B2 (en) 2008-12-09
US20060127382A1 (en) 2006-06-15
WO2006023502A2 (en) 2006-03-02
US8142993B1 (en) 2012-03-27
US20120085651A1 (en) 2012-04-12
US20160106779A1 (en) 2016-04-21
US20090092679A1 (en) 2009-04-09

Similar Documents

Publication Publication Date Title
WO2006023502A3 (en) Particle/cell separation device and compositions
WO2006017274A3 (en) Systems and methods for sample modification using fluidic chambers
WO2007006049A3 (en) Apparatuses, systems, and methods for isolating and separating biological materials
IL169792A0 (en) Autologous or homologous coagulant produced from anticoagulated whole blood
IL172546A0 (en) Methods for fabrication , uses and compositions of small spherical particles prepared by controlled phase separation
EP1580551A4 (en) Plasma or serum separation membrane and filter apparatus including the plasma or serum separation membrane
AU2003299682A1 (en) Device for the determination of blood clotting by capacitance or resistance
WO2006012352A3 (en) Blood component separation system with stationary separation chamber
WO2007127841A3 (en) Compositions and methods of preparation thereof
WO2007076032A3 (en) Compositions and methods for producing a composition
PT1765866E (en) Isolation of plasma or serum proteins
WO2005111083A3 (en) Antibodies specific for glycoprotein vi and methods of producing these antibodies
GB0709533D0 (en) Platelets from stem cells
SG113556A1 (en) Graft copolymers, method of making and compositions containing the same
EP1793906A4 (en) Blood separator and method of separating a fluid fraction from whole blood
WO2008027600A3 (en) Imatinib compositions
WO2005047494A3 (en) Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them
EP1640716A4 (en) Blood cell separation membrane and blood retention tool including the same
AU2003252316A1 (en) Method of preparing platelet rich plasma
WO2006013069A3 (en) Method and means for obtaining platelet rich plasma
DK1689516T3 (en) Separation of solid particles from the liquid in which they are dispersed
EP1723959A4 (en) Composition comprising platelet-rich plasma
WO2006116498A3 (en) Purified form of tanaproget
GB0605478D0 (en) Separation of components of jitter
AU2003213066A1 (en) Composite fluid separator

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase